Clinical utility of flumazenil-PET versus [ 18 F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients

Author： Ryvlin P Bouvard S Le Bars De De Lamérie G Grégoire MC Kahane P Froment JC Mauguiére F

Publisher： Oxford University Press

ISSN： 1460-2156

Source： Brain, Vol.121, Iss.11, 1998-11, pp. : 2067-2081

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

¹⁸F-fluorodeoxyglucose-PET as a biomarker in Huntington’s disease

By Ciarmiello Andrea Squitieri Ferdinando

Neurodegenerative Disease Management, Vol. 3, Iss. 6, 2013-12 ,pp. : 489-491

Future Medicine

Access to resources Recommend Favorite

Grey and white matter flumazenil binding in neocortical epilepsy with normal MRI. A PET study of 44 patients

By Hammers A.

Brain, Vol. 126, Iss. 6, 2003-06 ,pp. : 1300-1318

Oxford University Press

Access to resources Recommend Favorite

MRI-Guided Flumazenil- and FDG-PET in Temporal Lobe Epilepsy

By Szelies B. Weber-Luxenburger G. Pawlik G. Kessler J. Holthoff V. Mielke R. Herholz K. Bauer B. Wienhard K. Heiss W.-.D.

NeuroImage, Vol. 3, Iss. 2, 1996-04 ,pp. : 109-118

Academic Press

Access to resources Recommend Favorite

By Bouvard Sandrine

Brain, Vol. 128, Iss. 6, 2005-06 ,pp. : 1330-1343

Oxford University Press

Access to resources Recommend Favorite

Quantification of F-18 FDG PET Images in Temporal Lobe Epilepsy Patients Using Probabilistic Brain Atlas

By Kang K.W. Lee D.S. Cho J.H. Lee J.S. Yeo J.S. Lee S.K. Chung J-K. Lee M.C.

NeuroImage, Vol. 14, Iss. 1, 2001-07 ,pp. : 1-6

Academic Press

Access to resources Recommend Favorite